
PRDA to take subsidiary public
19 Feb 2025 08:41
Prodia readies its subsidiary, Proline, to debut on the stock market in the next 2-3 years.
19 Feb 2025 08:41
Prodia readies its subsidiary, Proline, to debut on the stock market in the next 2-3 years.
28 Jun 2024 12:51
PT Prodia Widyahusada Tbk (PRDA) takes an extra measure to secure supply chain of in vitro diagnostic (IVD) test tools by acquiring 39% of its affiliate, PT Prodia Diagnostic Line (Proline).
25 Jun 2024 15:07
PT Prodia Diagnostic Line (Proline), "sister company" of PT Prodia Widyahusada Tbk (PRDA) which is engaged in manufacturing reagents and test equipment, has just held the topping off of its newest production facility building today (25/6) in the Jababeka area, Cikarang.
18 Apr 2024 16:06
PT Prodia Widyahusada Tbk (PRDA) has prepared moderate amount of capital expenditure (capex) in 2024, worth a maximum of IDR 250 billion.
11 Dec 2023 13:55
PT Prodia StemCell Indonesia (ProSTEM), sister company of PT Prodia Widyahusada Tbk (PRDA), officially inaugurates Advanced Cell Therapy-Production Laboratory (ACT-PLab) phase one today (11/12) in Kramat, not far from Prodia headquarter at Prodia Tower.
27 Sep 2023 18:11
PT Prodia Widyahusada Tbk (PRDA) encourages investment in the healthcare sector whilst opening up for any investment opportunities in the future.
13 Apr 2023 11:23
PT Prodia Widyahusada Tbk (PRDA) has consistently distributed dividends in the 2022 fiscal year of IDR 237.9 per share, despite recording a decline in revenue and profit due to normalization after the COVID-19 pandemic.